Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, et al.
2024-02-01 • Lancet Respiratory Medicine
2024-02-01 • Lancet Respiratory Medicine
BACKGROUND Around 500,000 people worldwide develop rifampicin-resistant tuberculosis each year. The proportion of successful treatment outcomes remains low and new treatments are nee...
du Cros PAK, Greig J, Cross GB, Cousins C, Berry C, et al.
2023-12-01 • International Journal of Tuberculosis and Lung Disease
2023-12-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND The value, speed of completion and robustness of the evidence generated by TB treatment trials could be improved by implementing standards for best practice.
METH...
2017-05-01 • Bulletin of the World Health Organization
